Skip to Main Content

Jan Philipp Bewersdorf, MD, FACP

he/him/his
Hematology, Hematologic Oncology, Leukemia & Lymphoma
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Hematology (Internal Medicine)

Biography

Jan Philipp Bewersdorf, MD, specializes in hematology with a focus on the treatment of myeloid malignancies, including myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.

These conditions involve the abnormal development of blood cells and can present with symptoms such as fatigue, recurrent infections, and easy bruising.

“Leukemia unfortunately remains a life-threatening disease. However, not all forms of leukemia are equal, and I seek to empower my patients with information that is tailored to their individual situation and needs,” he says. “We have many effective therapies already available that can prolong life and improve quality of life. I remain optimistic that soon there will be additional therapies available that are even more potent than what we have today.”

Building relationships with his patients and their families is one of the most rewarding parts of his job, Dr. Bewersdorf says.

"It is a great privilege to take care of patients with leukemia and to support them and their families on this journey,” herf says. “Getting to know them as individual patients is very important to me and motivates me to work harder every day as I strive to treat every patient as I would like my family member. Knowing that I can make a positive impact on my patient's lives makes me most excited about my work.”

In his research, Dr. Bewersdorf collaborates with laboratory-based colleagues to integrate basic research with clinical applications, aiming to uncover new therapeutic strategies for diseases of the blood and bone marrow. "While we still cannot cure all patients with leukemia, we do have effective therapies available thanks to ongoing research efforts,” he says.

An assistant professor of medicine at Yale School of Medicine, Dr. Bewersdorf completed his medical education at Ludwig-Maximilians-University Munich and his internal medicine residency at Yale New Haven Hospital. He further specialized through a fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center.

Titles

  • Assistant Professor

Education & Training

  • Chief Fellow
    Memorial Sloan Kettering Cancer Center (2024)
  • Fellowship
    Memorial Sloan Kettering Cancer Center (2024)
  • Resident
    Yale - New Haven Hospital (2021)
  • Resident
    Ludwig-Maximilians-University Munich (2018)
  • MD
    Ludwig-Maximilians-University Munich (2017)

Languages Spoken

  • English
  • Deutsch (German)

Additional Information

Locations
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Wing NP Fl 7
New Haven, CT 06511

Biography

Jan Philipp Bewersdorf, MD, specializes in hematology with a focus on the treatment of myeloid malignancies, including myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.

These conditions involve the abnormal development of blood cells and can present with symptoms such as fatigue, recurrent infections, and easy bruising.

“Leukemia unfortunately remains a life-threatening disease. However, not all forms of leukemia are equal, and I seek to empower my patients with information that is tailored to their individual situation and needs,” he says. “We have many effective therapies already available that can prolong life and improve quality of life. I remain optimistic that soon there will be additional therapies available that are even more potent than what we have today.”

Building relationships with his patients and their families is one of the most rewarding parts of his job, Dr. Bewersdorf says.

"It is a great privilege to take care of patients with leukemia and to support them and their families on this journey,” herf says. “Getting to know them as individual patients is very important to me and motivates me to work harder every day as I strive to treat every patient as I would like my family member. Knowing that I can make a positive impact on my patient's lives makes me most excited about my work.”

In his research, Dr. Bewersdorf collaborates with laboratory-based colleagues to integrate basic research with clinical applications, aiming to uncover new therapeutic strategies for diseases of the blood and bone marrow. "While we still cannot cure all patients with leukemia, we do have effective therapies available thanks to ongoing research efforts,” he says.

An assistant professor of medicine at Yale School of Medicine, Dr. Bewersdorf completed his medical education at Ludwig-Maximilians-University Munich and his internal medicine residency at Yale New Haven Hospital. He further specialized through a fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center.

Titles

  • Assistant Professor

Education & Training

  • Chief Fellow
    Memorial Sloan Kettering Cancer Center (2024)
  • Fellowship
    Memorial Sloan Kettering Cancer Center (2024)
  • Resident
    Yale - New Haven Hospital (2021)
  • Resident
    Ludwig-Maximilians-University Munich (2018)
  • MD
    Ludwig-Maximilians-University Munich (2017)

Languages Spoken

  • English
  • Deutsch (German)

Additional Information

Locations
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Wing NP Fl 7
New Haven, CT 06511
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Wing NP Fl 7
New Haven, CT 06511